Regulus Therapeutics Inc.'s (NASDAQ:RGLS) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week [Yahoo! Finance]
Regulus Therapeutics Inc. (RGLS)
Last regulus therapeutics inc. earnings: 3/12 04:37 pm
Check Earnings Report
US:NASDAQ Investor Relations:
regulusrx.com/investors
Company Research
Source: Yahoo! Finance
The top 5 shareholders own 52% of the company Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business Every investor in Regulus Therapeutics Inc. ( NASDAQ:RGLS ) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 48% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). And as as result, institutional investors reaped the most rewards after the company's stock price gained 11% last week. One-year return to shareholders is currently 72% and last week's gain was the icing on the cake. Let's take a closer look to see what the different types of shareholders can tell us about Regulus Therapeutics. Check out our latest analysis for Regulus Therapeutics What Does The Institutional Ownership Tell Us About Regulus Therapeutics? Institutions typically measure themselves against a benchmark when reporti
Show less
Read more
Impact Snapshot
Event Time:
RGLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGLS alerts
High impacting Regulus Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
RGLS
News
- Regulus Therapeutics Inc. (NASDAQ: RGLS) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Regulus Therapeutics Inc. (NASDAQ: RGLS) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Regulus Therapeutics Announces Participation at Two Healthcare Investment ConferencesPR Newswire
- Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $7.00 price target on the stock.MarketBeat
- Companies Like Regulus Therapeutics (NASDAQ:RGLS) Are In A Position To Invest In Growth [Yahoo! Finance]Yahoo! Finance
RGLS
Earnings
- 8/8/24 - In-Line
RGLS
Sec Filings
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- 7/29/24 - Form 4
- RGLS's page on the SEC website